Homepage
  History
  Charity Information
Officers | Executive Committee
Sections | Working Groups
Member Societies
Fundings, Awards & Honours
  Fellowship
  Meritorious & Honorary Membership
  Hamao Umezawa Memorial Award
  Young Investigator Travel Awards
  Inter-American Society of Chemotherapy (IASC) Award
  ISC African Travel Bursaries
  Memorial Awards
  Masaaki Ohkoshi Award
  Yen Award
ISC Committees
ISC-on-LINE
International Journal of Antimicrobial Agents
Future Meetings
Past Meetings
  2011
  2010
  2009
  2008
  2007
  2006
  2005
Archives
Contact

ISC Working Group on the Collateral Effects of Anti-infectives

Committee
Introduction
Aims of the Working Group
Working Plan
Meetings

Committee
Chairperson

Mihai Nechifor (Iasi, Romania)
E-mail:  mihai.nechifor@farmac-s.umfiasi.ro

Secretary

Irina Gradinaru (Iasi, Romania)
E-mail:  irigrad@yahoo.com

Committee members

Guillermo Acuna (Santiago, Chile)
Luccila Baldassari (Rome, Italy)
Luis Bavestrello (Vina del Mar, Chile)
Irina Codita (Bucharest, Romania)
Roberta Creti (Rome, Italy)
Gabriel Levy Hara (Buenos Aires, Argentina)
Elena Ushkolova (Moscow, Russia)

Introduction
The ISC Working Group on Collateral Effects of Anti-infectives was founded during a DMS Conference in Bucharest, 4 – 6 October 2006, chaired by Mihai Nechifor (Lasi, Romania) and the late Jean Claude Pechere (Geneva, Switzerland).

Aims of the Working Group

  1. Increasing the ADRs report correctness regarding the anti-infective drugs in hospitalized patients and outpatients.
  2. ADRs in the cases of self medication with anti-infective drugs.
  3. ADRs study in on-label versus off-label use of the anti-infective drugs.
  4. Study about the ADRs in prophylactic use of anti-infectives.
  5. Pathways and methods to decrease ADRs incidence.

Working Plan

  • To organise a symposium in the 27th ICC / 21st ECCMID, Milan, Italy, 2011.
  • To continue the surveillance activity of the adverse reactions of the anti-infective drugs and the economical impact.
  • To start research about the adverse reactions in the case of the off label use of the anti-bacterials.
  • To increase the number of members in our working group.
  • To present papers in the international scientific meetings.

Meetings

  1. First International Conference “Collateral Effects of Anti-infective Drugs” Bucharest, 4 – 6 October 2006.
  2. Meet the Experts in 26th International Congress of Chemotherapy, Toronto 2009.
  3. Symposium at the 1st South-eastern European Conference on Chemotherapy & Infection, Varna, Bulgaria 2010.
  4. Surveillance of adverse reactions of anti-infective drugs.
  5. Start of research about the differences in the incidence of ADRs upon age.
  6. Start of research about the ADRs in on-label versus off-label use of anti-bacterial drugs.

For further information on ISC meetings go to:

ISC Future Meetings
ISC Past Meetings

Last edition: Mars 3, 2011

International Society of Chemotherapy
webdesign cos